Exciva
Exciva develops clinical-stage biopharmaceutical therapies focused on addressing neuropsychiatric symptoms associated with dementia, including agitation and aggression in Alzheimer’s disease. It applies a targeted drug rescue approach that identifies and repurposes previously approved or clinically tested compounds into new therapeutic candidates. Exciva conducts scientific research and clinical studies to evaluate safety and potential effectiveness of its investigational products in neuropsychiatry. Its programs include formulations and methods designed for symptomatic relief and improved behavioral outcomes. Exciva collaborates with scientific and medical professionals to advance its pipeline through regulated trial phases and regulatory processes.
Tech Stack (11 technologies)
Frequently Asked Questions
What technologies does Exciva use?+
Exciva uses 11 technologies including Sentry, Wix, React.
What industry is Exciva in?+
Exciva operates in the Biotechnology industry.
Where is Exciva based?+
Exciva is headquartered in Germany.
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026